Zhejiang, China
NCT Number: NCT04776603
A Comparison of the Accuracy of Toric Intraocular Lens Formulas
To compare the accuracy of the Abulafia-Koch, the Barrett, the Barrett Post ,the EVO , the new Holladay with total surgical-induced astigmatism, the Kane and and the Næser-Savini toric intraocular lens (IOL) power formulas using a large database of toric IOL refractive outcomes
Looking for future studies?
Notify MeKey information
Age range
21 year–90 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
To compare the accuracy of the Abulafia-Koch, the Barrett, the Barrett Post ,the EVO , the new Holladay with total surgical-induced astigmatism, the Kane and and the Næser-Savini toric intraocular lens (IOL) power formulas using a large database of toric IOL refractive outcomes.Retrospective consecutive case series.One hundred seventy-two eyes of 172 patients who had a toric IOL inserted during surgery.One eligible eye from patients having uncomplicated cataract surgery with insertion of an Alcon SN6AT(2-9) IOL (Alcon Laboratories, Inc, Fort Worth, TX) from 1 surgeon were included in the study. pre-operative were measured using either the IOLMaster 500 or 700 (Carl Zeiss Meditec AG, Jena, Germany). Using vector calculation, the predicted postoperative refractive astigmatism was calculated for each formula. This was compared with the actual postoperative refractive astigmatism to give the prediction error.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- uncomplicated cataract surgery with a temporal clear corneal incision,with preoperative biometry using either the IOLMaster 500 (softwareversions 5.5 and 7.7) or 700 (software version 1.50; Carl Zeiss Meditec AG, Jena, Germany)
- subjective manifest refraction performed by any of the orthoptists in the practice and measurement of the actual postoperative axis of the IOL alignment performed in the same visit an average of 1 or 3months after surgery.
Exclusion criteria
- any corneal disease (keratoconus, other ectasia, pterygium, or previous trauma);
- previous ophthalmic operations, including laser vision correction, vitrectomy, pterygium surgery, penetrating glaucoma surgery, or scleral buckling procedures
- intraoperative or postoperative complications
- postoperative corrected distance visual acuity worse than 6/9
Treatment and study plan
Primary outcomes
-
A Comparison of the Accuracy of Toric Intraocular Lens Formulas
Time frame: 5 years
percentage of eyes with a prediction error within ±0.50 diopter (D)
Sponsors and collaborators
Lead sponsor
Wenzhou Medical University
Other
Registry information
Official study title
A Comparison of the Accuracy of Many Different Toric Intraocular Lens Formulas
Important dates
- Study start
- 2015
- Primary completion
- 2019
- Study completion
- 2020
- First posted
- Mar 1, 2021
- Registry last updated
- Mar 1, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)
NCT06784063
Astigmatism, Cataract
Bloomfield Hills, Michigan, United States
View Trial DetailsInvestigation of the Safety and Effectiveness of Monofocal Toric Intraocular Lens (IOL)
NCT06399211
Aphakia, Aphakia, Postcataract
View Trial DetailsObservational Prospective Clinical Investigation on Monofocal Toric Intraocular Lens
NCT06250855
Astigmatism, Cataract
Bacau, Romania
View Trial DetailsRefractive Accuracy of Toric Intraocular Lens Implantation Using Digital Marking Compared to Conventional Marking
NCT07176897
Astigmatism, Cataract
Encino, California, United States
View Trial Details